Similar Search Results

Cockburn, Iain M.; Anis, Aslam H. - 2021

We examine the relationship between quality'' and market outcomes for a group of drugs used to treat rheumatoid arthritis. Though this is a widespread and debilitating disease with very substantial impacts on the health of patients and on the economy, currently available drugs have limited...

Persistent link: https://www.econbiz.de/10013222962

Immunization and Moral Hazard : The Hpv Vaccine and Uptake of Cancer Screening

Moghtaderi, Ali - 2016

HPV vaccination for cervical cancer on participation in the Pap test, which is a diagnostic screening test to detect … HPV vaccine. A reduction in willingness to have a Pap test as a result of HPV vaccination would signal the need for public … health intervention. The HPV vaccination is recommended for women age eleven to twelve for regular vaccination or for women …

Persistent link: https://www.econbiz.de/10012984769

The Local Influence of Pioneer Investigators on Technology Adoption : Evidence from New Cancer Drugs

Agha, Leila - 2015

paper analyzes the influence of physician investigators who lead clinical trials for new cancer drugs. By comparing … diffusion patterns across 21 new cancer drugs, we separate correlated regional demand for new technology from information …

Persistent link: https://www.econbiz.de/10013029559

Pandemics, Vaccines and an Earnings Damage Function

Hong, Harrison G.; Kubik, Jeffrey D.; Wang, Neng; Xu, Xu; … - 2021

We derive a parsimonious model of damage to corporate earnings from COVID-19. Using measures of expected damage from industry-level earnings forecast revisions, we estimate this model with nonlinear least squares and identifying restrictions related to forecast rationality. Forecasts in mid-May...

Persistent link: https://www.econbiz.de/10013245116

Price Indices and the Value of Innovation with Heterogenous Patients

Lucarelli, Claudio; Nicholson, Sean; Tilipman, Nicholas - 2022

- adjusted price indices for colorectal cancer drug treatments. We find that while the efficacy gains from newer drugs do not … justify high prices for the population as a whole, innovation improves the welfare of sicker, late-stage cancer patients. A …

Persistent link: https://www.econbiz.de/10014241448

Leakage, Welfare, and Cost-Effectiveness of Carbon Policy

Baylis, Kathy - 2014

We extend the model of Fullerton, Karney, and Baylis (2012 working paper) to explore cost-effectiveness of unilateral climate policy in the presence of leakage. We ignore the welfare gain from reducing greenhouse gas emissions and focus on the welfare cost of the emissions tax or permit scheme....

Persistent link: https://www.econbiz.de/10013064305

Net Health Benefits : A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis

Stinnett, Aaron A.; Mullahy, John - 2021

In recent years, considerable attention has been devoted to the development of statistical methods for the analysis of uncertainty in cost-effectiveness analysis, with a focus on situations in which the analyst has patient-level data on the costs and health effects of alternative interventions....

Persistent link: https://www.econbiz.de/10013216128

Accounting for Future Costs in Medical Cost-Effectiveness Analysis

Meltzer, David - 2021

Most medical cost-effectiveness analyses include future costs only for related illnesses but this approach is controversial. This paper demonstrates that cost-effectiveness analysis is consistent with lifetime utility maximization only if it includes all future medical and non-medical...

Persistent link: https://www.econbiz.de/10013235873

Advances in Cost-Effectiveness Analysis of Health Interventions

Garber, Alan M. - 2021

The growing application of cost-effectiveness (CE) analysis and controversies about its methods has led to a need to explore its welfare economic foundations. Examination of its welfare theoretic foundations can provide a rationale for selecting specific standards for the application of CE...

Persistent link: https://www.econbiz.de/10013244105

The Cost-Effectiveness of Alternative Instruments for Environmental Protection in a Second-Best Setting

Goulder, Lawrence H.; Parry, Ian W. H.; Williams, … - 2021

This paper uses analytical and numerical general equilibrium models to study the costs of achieving pollution reductions under a range of environmental policy instruments in a second-best setting with pre-existing factor taxes. We compare the costs and efficiency impacts of emissions taxes,...

Persistent link: https://www.econbiz.de/10013244739

1
2
3
4
5
6
7
8
9
10
Next
Last